Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the 10 best penny stocks that could triple your money. On February 26, Akebia Therapeutics Inc. (NASDAQ:AKBA) outlined its 2026 pipeline expansion and ...

Akebia Therapeutics (NASDAQ:AKBA) outlined its commercial priorities for Vafseo, the expected evolution of reimbursement ...

We recently published a list of Thursday’s 10 Worst-Performing Stocks. In this article, we are going to take a look at where Akebia Therapeutics Inc. (NASDAQ:AKBA) stands against other Thursday’s ...

Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.

Akebia Therapeutics develops and markets therapies for people living with chronic kidney disease. Its key commercial products are Vafseo, an oral medicine that treats anemia in adults undergoing ...

Akebia Therapeutics (AKBA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful ...